Services

The Myeloscreen kits allow the identification of specific fusion genes, present in diseases of myeloproliferative nature. These kits are based on a new multiplex PCR design, which allows simultaneous detection of the presence of the different isoforms of the existing translocation, by means of a one-step quantitative RT-PCR reaction (qRT-PCR ONE-STEP), from RNA samples. This system has an analysis tool that facilitates this work and allows obtaining the results in a very simple way. Currently we have kits for PML-RARA and BCR-ABL, allowing the detection of all isoforms described.